Nicole Mittmann

Canadian Agency for Drugs and Technologies in Health

Also affiliated with Sunnybrook Health Science Centre, University of Toronto, Ottawa Hospital, Health Sciences Centre, Ottawa Hospital Research Institute, Sunnybrook Research Institute

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia”.

A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.06.011

N/A

0DataRank · unranked

5 citations

Nicole Mittmann, Carolyn Owen, Nizar Abdel‐Samad, Graeme Fraser, Selay Lam +15 more